Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of March 2021. The document serves as a notice regarding the publication of the 2021 Annual General Meeting (AGM) details.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this document.
Guidance, Outlook, and Management Commentary
- AGM Logistics: The 2021 AGM is scheduled for Wednesday, 5 May 2021, at 2:30 pm at the Company's registered office in Brentford, Middlesex.
- Attendance Restrictions: Due to UK Government COVID-19 restrictions, shareholders are not permitted to attend the AGM physically.
- Virtual Participation: The meeting will be broadcast live, and shareholders are invited to join electronically. The Company is maximizing existing technology to facilitate participation.
- Documentation: The Notice of AGM and AGM Guide have been published on the Company's website and will be submitted to the UK Listing Authority.
Key Facts for Investor Verification
- Verify the date and time of the 2021 AGM: 5 May 2021 at 2:30 pm.
- Confirm the method of shareholder participation is electronic only due to pandemic restrictions.
- Review the 2021 AGM Notice and AGM Guide available on the GSK investor website for voting instructions and agenda details.
- Note that this filing contains no financial results; refer to Form 20-F or quarterly reports for financial data.